Sol-Gel Technologies vs Verrica Pharmaceuticals
SLGL and VRCA side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How SLGL and VRCA compare
Sol-Gel Technologies grew revenue faster over the last twelve months (68.0% versus −25.7% for Verrica Pharmaceuticals).
Sol-Gel Technologies keeps more of each dollar of sales as profit, with a net margin of −31.6% compared with −189% at Verrica Pharmaceuticals.
Sol-Gel Technologies scores higher on the StockData Score (10 against 4 for Verrica Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | SLGL | VRCA |
|---|---|---|
| Size and price | ||
| Market cap | – | $61.2M |
| Share price | $55.12 | $3.56 |
| Change, 1 year | 75.0% | −6.8% |
| Change, 5 years | −35.7% | −96.9% |
| Beta (5Y) | 1.00 | 1.08 |
| Employees | 28 | 76 |
| StockData Score | ||
| Total score | 10 (better) | 4 |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 3 (better) | 1 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 2.7× |
| Growth | ||
| Revenue growth (TTM) | 68.0% (better) | −25.7% |
| Revenue growth, 5Y average | 17.2% | – |
| Profitability | ||
| Operating margin | −38.9% (better) | −184% |
| Net margin | −31.6% (better) | −189% |
| FCF margin | 1.4% | – |
| Return on equity | −15.3% | – |
| Return on invested capital | −153% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −21.9× |
| Current ratio | 10.37 (better) | 1.66 |
| Altman Z-score | – | −14.33 |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 47.5% | 27.1% |
| Held by insiders | 70.2% | – |
| Insider net buying, 12 months | $11.0M (better) | $211K |
| Short interest, % of float | 16.3% | – |
Go deeper
- SLGL stock overview
- SLGL income statement
- SLGL valuation and score
- VRCA stock overview
- VRCA income statement
- VRCA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.